To help protect yourself and your family from getting seriously ill, you may want to learn about additional vaccine options ...
The 2024-2025 COVID-19 vaccines offered protection against COVID-19-associated ED and urgent care visits among pediatric populations in the US.
A fast-spreading H3N2 flu strain is driving an unusually intense early season in the U.S., with millions of illnesses and ...
Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the EU approval of mNexspike (mRNA-1283). This is MRNA’s next-generation refrigerator-stable COVID ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...
DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
The Department of Health says there is "no shortage" of Pfizer COVID-19 vaccines in New Brunswick, but with holiday gatherings quickly approaching, people should not put off getting a shot, hoping for ...
The vaccines were found to decrease the risk of needing medical care in the first six months after vaccination by 76 percent in children under 4, and by 56 percent in children 5 to 17. By Apoorva ...